Radar › Companies › Healthcare · Nouvelle Aquitaine
Radar · Healthcare in Nouvelle Aquitaine

Best Healthcare Companies in Nouvelle Aquitaine, France

The 32 best Healthcare companies in Nouvelle Aquitaine, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: OP2 Drugs.

32companies tracked
$12.2Mdisclosed funding
0unicorns
6have raised

Ranked: Best Healthcare companies in Nouvelle Aquitaine

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackPatents & IP focusRecent signals
1OP2 Drugs
R&D company focused on manufacturing of life saving drugs
$4M108 mo agoDeadpooledDominique Detaille
Co-Founder
2015—38 patents
Patents concentrated in health & consumer products
—
2MitoProd
Developer of technology for the production of ribonucleic acids
$3M—DeadpooledGuillaume Plane
Founder & CEO
2004———
3Valbiotis
Developer of products for the prevention and treatment of chronic metabolic diseases
$2M66 mo agoPublic—2014WordPressMySQLPHP+17119 patents
Plant‑derived nutraceutical compositions targeting metabolic disorders and inflammatory bowel disease
—
4Certis Therapeutics
Provider of software development, MRI, and other services
$2M61 mo agoSeedStephane Chemouny
CEO
2019———
5B-cell design
Develops immuno therapeutic solution for diseases
$705K137 mo agoSeedGael Champier
Co-Founder
2007—25 patents
Patents concentrated in chemistry & materials
—
6Ernesti
Provider of diversified healthcare services
$366K71 mo agoSeedSeverine Zakoian
Co-Founder
2018WebflowVWOCloudflare Turnstile+16——
7Technoflex
Developer of IV drug delivery supplies
—69 mo agoPublicOlivier Chesnoy
CEO
1972WordPressMySQLPHP+17151 patents
Flexible infusion bags, connectors, and sterile medical packaging for intravenous delivery
—
8Addidream
Designer and manufacturer of medical devices
—103 mo agoSeedWilliam Allaine
Co-Founder
2017—2 patents
Computer-aided design and manufacturing of custom bone models for medical use
—

Top 8 Healthcare companies in Nouvelle Aquitaine

#1
Seed · Bordeaux, Nouvelle Aquitaine · founded 2019 · 15 employees
$1.7Mraised
▾

Developer of imaging-guided thermo-ablation medical devices designed to treat cardiac pathologies, cancers and neurological disorders. The company's devices combine software elements and minimally invasive therapy, including advanced image processing modules on real-time MRI guidance to improve the efficacy of cardiac electric disorders, enabling researchers to optimize the use of existing thermal ablation equipment, for safe and effective procedures.

Funding rounds
  • Sep 2021Seed$1.7M
Founders & team
Stephane ChemounyCEO
Investors
Aquiti Gestion, Grand Sud Ouest Capital, Credit Agricole, MEDEVICE, Naco
#2
Public · La Rochelle, Nouvelle Aquitaine · founded 2014 · 48 employees
$2.4Mraised
▾

Developer of products for the prevention and treatment of chronic metabolic diseases

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 12.7% of this cohort's audience · 49 engagements/post (2.4× cohort median)
Activity: 1 product launches · 1 partnerships (incl. La Rochelle Université LIENSs - CNRS / La Rochelle Université, l'Université Clermont Auvergne ou le CNRS) announced in 12 mo
Funding rounds
  • Apr 2021Post IPO$17.9M
  • Jan 2017Grant (prize money)—
  • May 2016Seed$2.4M
Investors
Nestadio Capital, Sofimac Investment Managers, Bpifrance, Europa, Eiffel Investment Group, Aquiti Gestion
Tech stack
Apache Http ServerAutoptimizeAvis VerifiesAxeptioAxiosBootstrap
#3
Seed · Bordeaux, Nouvelle Aquitaine · founded 2018 · 34 employees
$366Kraised
▾

Developer of a home support platform designed to provide night support for elders at home. The company's platform connects individuals with a loss of autonomy as well as their families with students in medical or paramedical school, enabling families to be informed in real time of what is happening at the home of their loved ones.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 3.6% of this cohort's audience
Funding rounds
  • Nov 2020Seed$366K
Founders & team
Severine ZakoianCo-FounderQuentin ZakoianCo-Founder & CEO
Investors
Paris Business Angels, 50 Partners, ZAM Capital
Tech stack
ApolloBrowser-Update.OrgCalendlyCloudflareCloudflare Bot ManagementCloudflare Browser Insights
#4
Deadpooled · Pessac, Nouvelle Aquitaine · founded 2015 · 4 employees
$4.1Mraised
▾

Developer of medicines and drugs platform intended to apply in cardioprotection and neuroprotection. The company's platform develops medicines and identified them with a flexible economic model, enabling physicians to treat cardiac and neurological problems.

Funding rounds
  • Oct 2017Series A$4.1M
Founders & team
Dominique DetailleCo-FounderNicolas PineauCo-Founder & COOPhilippe PasdoisCo-Founder
Investors
Aquiti Gestion, Bpifrance, Nouvelle-Aquitaine
#5
Deadpooled · Bordeaux, Nouvelle Aquitaine · founded 2004
$2.8Mraised
▾

MitoProd develops and markets Ribonucleic Acids (RNA). It produces RNA from yeast fermentation though mitochondrial transformation and DNA transcription processes. The company also develops cell cultures for RNA production. Its products find use in the treatment of cancer, viral infections, Alzheimer’s disease, and Parkinson’s disease. The company’s partners include SAF-ISIS, Sibio, Club Alfa, Biotechnica, GIPSO, ANVAR, Région Aquitaine, and CNRS.

Founders & team
Guillaume PlaneFounder & CEO
#6
Seed · Limoges, Nouvelle Aquitaine · founded 2007 · 5 employees
$705.4Kraised
▾

B-cell design uses its proprietary technology of Transgenic mouse model to develop antibodies. They have three mouse lines Human Chimeric IgA1 ( a good number of B-cells produce IgA isotype), Human chimeric IgG1, and Human chimeric IgM and IgE, produced by in vitro class switching (IgM-producing B cells produce IgE after class switching) for antibody development. B-cell design has a vaccine targeting HIV ( an antigen of the natural microbial flora triggering mucosal immune response which neutralizes HIV effect) and an IgA antibody against colorectal cancer (targeting mucosal areas and associated glands and increasing the cytotoxicity in turn). It also runs research programs centered around mucosal immunity to develop drug candidates against mucosal cancers and mucosal infectious diseases.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers — 2.8% of this cohort's audience
Funding rounds
  • Jun 2015Angel$705.4K
Founders & team
Gael ChampierCo-FounderArmelle CuvillierCo-Founder
Investors
Les Business Angels des Grandes Écoles, Limousin Participations
Tech stack
WordpressMysqlPhpApache Http Server
#7
Public · Bidart, Nouvelle Aquitaine · founded 1972 · 275 employees
—raised
▾

Manufacturer of flexible bags and medical devices intended to serve the pharmaceutical industry. The company specializes in designing and providing various types of flexible bags and medical devices such as polypropylene, sterile, multi-chamber bags and connectors for generic drug laboratories.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 6.8% of this cohort's audience · 36 engagements/post (1.8× cohort median)
Founders & team
Olivier ChesnoyCEO
Investors
Ministry of Economy, Finance and Industrial and Digital Sovereignty, XAnge, Credit Mutuel Equity
Tech stack
AxeptioContact Form 7FancyboxGoogle AnalyticsGoogle Font ApiGoogle Tag Manager
#8
Seed · Limoges, Nouvelle Aquitaine · founded 2017 · 10 employees
—raised
▾

Designer and manufacturer of medical devices

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 5.4% of this cohort's audience
Funding rounds
  • Mar 2018Seed—
Founders & team
William AllaineCo-FounderClement MuhleCo-Founder & CEO
Investors
I.CERAM

Funding & investor landscape

$12.2Mtotal disclosed funding
6companies funded
6disclosed rounds
0rounds last 90 days
Most active investors
Aquiti Gestion5 rounds
Bpifrance3 rounds
Eiffel Investment Group2 rounds
Ouest Croissance2 rounds
XAnge2 rounds
50 Partners1 rounds
Biogroup LCD1 rounds
CAPZA1 rounds
CDPQ1 rounds
CLINIQUE SAINT GATIEN1 rounds

Notable founders

Stephane Chemouny
CEO · Certis Therapeutics
Severine Zakoian
Co-Founder · Ernesti
Quentin Zakoian
Co-Founder & CEO · Ernesti
Dominique Detaille
Co-Founder · OP2 Drugs
Nicolas Pineau
Co-Founder & COO · OP2 Drugs
Guillaume Plane
Founder & CEO · MitoProd
Gael Champier
Co-Founder · B-cell design
Armelle Cuvillier
Co-Founder · B-cell design
Olivier Chesnoy
CEO · Technoflex
William Allaine
Co-Founder · Addidream
Clement Muhle
Co-Founder & CEO · Addidream
Prism market signals · France · country-scoped Prism corpus, 2,075,693 docs

Market landscape — 10 sub-themes by coverage

Share of Healthcare coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

Common questions

How many Healthcare companies are there in Nouvelle Aquitaine, France?
Radar tracks 32 indexable Healthcare companies headquartered in Nouvelle Aquitaine, France that meet our profile-completeness bar.
What is the total funding raised by Healthcare companies in Nouvelle Aquitaine, France?
The Healthcare companies in Nouvelle Aquitaine, France on this list have raised a combined $12.2M in disclosed equity funding across 6 funded companies.
Which is the highest-funded Healthcare company in Nouvelle Aquitaine, France?
OP2 Drugs is the highest-funded Healthcare company in Nouvelle Aquitaine, France, with $4.1M in disclosed equity funding.
How many Healthcare companies in Nouvelle Aquitaine, France are funded?
6 of the 32 Healthcare companies in Nouvelle Aquitaine, France on this list have disclosed at least one equity funding round.
How many Healthcare unicorns are there in Nouvelle Aquitaine, France?
None of the Healthcare companies in Nouvelle Aquitaine, France on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Nouvelle Aquitaine, France Healthcare companies?
The most active investors in Nouvelle Aquitaine, France Healthcare companies on this list include Aquiti Gestion, Bpifrance, Eiffel Investment Group, Ouest Croissance, XAnge.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon